Hainan Huluwa Pharmaceutical Group Co Ltd (605199) — Net Asset Quality Index
Hainan Huluwa Pharmaceutical Group Co Ltd (605199) has a Net Asset Quality Index of 16.8% as of March 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of CN¥2.56 Billion minus total liabilities of CN¥2.13 Billion yields net assets of CN¥429.55 Million. A higher index indicates a stronger, lower-leverage balance sheet. Read debt load of Hainan Huluwa Pharmaceutical Group Co Lt for a breakdown of total debt and financial obligations.
Quality Index
Net Assets
Total Assets
Total Liabilities
Hainan Huluwa Pharmaceutical Group Co Ltd Net Asset Quality Index Over Time (2016–2025)
This chart shows how Hainan Huluwa Pharmaceutical Group Co Ltd's Net Asset Quality Index has evolved across 10 annual periods from 2016 to 2025. As of March 2026, the index stands at 16.8%, representing net assets of CN¥429.55 Million against total assets of CN¥2.56 Billion CNY. For live market cap and overall valuation, see how much is Hainan Huluwa Pharmaceutical Group Co Lt worth.
Annual Net Asset Quality Index for Hainan Huluwa Pharmaceutical Group Co Ltd (2016–2025)
The table below presents the year-by-year Net Asset Quality Index for Hainan Huluwa Pharmaceutical Group Co Ltd from 2016 to 2025, covering 10 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. Check Hainan Huluwa Pharmaceutical Group Co Lt strategic asset allocation index to assess the company's strategic physical and investment asset allocation.
| Year | Quality Index | Net Assets (CNY) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 17.6% | CN¥458.02 Million | CN¥2.60 Billion | CN¥2.14 Billion | ▼ -7.5 pp |
| 2024 | 25.1% | CN¥743.28 Million | CN¥2.96 Billion | CN¥2.22 Billion | ▼ -12.8 pp |
| 2023 | 37.9% | CN¥1.16 Billion | CN¥3.06 Billion | CN¥1.90 Billion | ▼ -6.0 pp |
| 2022 | 43.9% | CN¥1.02 Billion | CN¥2.31 Billion | CN¥1.30 Billion | ▼ -8.9 pp |
| 2021 | 52.8% | CN¥930.52 Million | CN¥1.76 Billion | CN¥830.41 Million | ▼ -7.4 pp |
| 2020 | 60.2% | CN¥916.48 Million | CN¥1.52 Billion | CN¥604.68 Million | ▲ +1.0 pp |
| 2019 | 59.3% | CN¥643.94 Million | CN¥1.09 Billion | CN¥442.67 Million | ▲ +3.9 pp |
| 2018 | 55.4% | CN¥604.61 Million | CN¥1.09 Billion | CN¥487.37 Million | ▲ +11.8 pp |
| 2017 | 43.5% | CN¥351.38 Million | CN¥807.21 Million | CN¥455.83 Million | ▲ +19.5 pp |
| 2016 | 24.0% | CN¥128.69 Million | CN¥535.95 Million | CN¥407.26 Million | — |